Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
November 22, 2008
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits
Roberta Baetta, Agnese Granata, Monica Canavesi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 1, 2019
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy
Marc Humbert, Jean Bousquet, Claus Bachert, et al.
ACS Catalysis
|
September 6, 2021
Engineering a Highly Efficient Carboligase for Synthetic One-Carbon Metabolism
Maren Nattermann, Simon Burgener, Pascal Pfister, et al.
Respiratory Research
|
April 24, 2020
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
Alexander J Mackay, Konstantinos Kostikas, Nicolas Roche, et al.
Elife
|
July 25, 2022
On the flexibility of the cellular amination network in <i>E coli</i>
Helena Schulz-Mirbach, Alexandra Müller, Tong Wu, et al.
Frontiers in Synaptic Neuroscience
|
September 5, 2019
Model-Based Inference of Synaptic Transmission
Ola Bykowska, Camille Gontier, Anne-Lene Sax, et al.
Respiratory Medicine
|
October 21, 2020
Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)" [Respir. Med. 170 (Aug-Sep 2020) 106021]
Christian Gessner, Oliver Kornmann, Jorge Maspero, et al.
Respiratory Medicine
|
August 27, 2020
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
Christian Gessner, Oliver Kornmann, Jorge Maspero, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 22, 2018
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial
Kenneth R Chapman, John R Hurst, Stefan-Marian Frent, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 22, 2021
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis
Alan Kaplan, Hui Cao, J Mark FitzGerald, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
The Journal of Pharmacology and Experimental Therapeutics
|
November 22, 2008
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits
Roberta Baetta, Agnese Granata, Monica Canavesi, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
April 1, 2019
IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy
Marc Humbert, Jean Bousquet, Claus Bachert, et al.
ACS Catalysis
|
September 6, 2021
Engineering a Highly Efficient Carboligase for Synthetic One-Carbon Metabolism
Maren Nattermann, Simon Burgener, Pascal Pfister, et al.
Respiratory Research
|
April 24, 2020
Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
Alexander J Mackay, Konstantinos Kostikas, Nicolas Roche, et al.
Elife
|
July 25, 2022
On the flexibility of the cellular amination network in <i>E coli</i>
Helena Schulz-Mirbach, Alexandra Müller, Tong Wu, et al.
Frontiers in Synaptic Neuroscience
|
September 5, 2019
Model-Based Inference of Synaptic Transmission
Ola Bykowska, Camille Gontier, Anne-Lene Sax, et al.
Respiratory Medicine
|
October 21, 2020
Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)" [Respir. Med. 170 (Aug-Sep 2020) 106021]
Christian Gessner, Oliver Kornmann, Jorge Maspero, et al.
Respiratory Medicine
|
August 27, 2020
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
Christian Gessner, Oliver Kornmann, Jorge Maspero, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 22, 2018
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial
Kenneth R Chapman, John R Hurst, Stefan-Marian Frent, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 22, 2021
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis
Alan Kaplan, Hui Cao, J Mark FitzGerald, et al.
Page
of 5